A Study in Healthy People to Test if Taking Different Formulations of BI 425809 Tablets Influences the Amount of BI 425809 in the Blood
Clinical trial NCT03817476 · COMPLETED
Trial details
- NCT number
- NCT03817476
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-11
- Primary completion
- 2019-05-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.